Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women

Daniel A. Dumesic, David H. Abbott, Joel R. Eisner, Rebekah R. Herrmann, Judd E. Reed, Timothy J. Welch, Michael Dennis Jensen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objective: To determine whether hyperandrogenism in anovulatory women affects body fat distribution. Design: Prospective nonrandomized study. Setting: An academic research environment. Patient(s): Ten hyperandrogenic anovulatory patients and 10 healthy women matched by body mass index. Intervention(s): Regional body fat analysis was performed before and after 3 months of GnRH analogue (GnRH-a) therapy. Main Outcome Measure(s): Body fat distribution was measured by waist-to-hip circumference ratio, single-slice computed tomography imaging (L2-3 interspace), and total body dual-energy x- ray absorptiometry. Result(s): Weight, body mass index, waist-to-hip circumference ratio, total body and leg fat mass, and subcutaneous adipose area were unaffected by the presence of hyperandrogenism or the use of GnRH- a therapy. Basal abdominal fat mass, abdomen-to-leg fat mass ratio, visceral adipose area, and total visceral adipose volume were comparable in both study groups. The abdominal fat mass increased in both groups during GnRH-a therapy, whereas the abdomen-to-leg fat mass ratio rose significantly only in the hyperandrogenic patients. During GnRH-a therapy, the hyperandrogenic patients demonstrated a significant increase in visceral adipose area compared with the healthy women so that total visceral adipose volume increased significantly in the former but not the latter. Conclusion(s): Three months of GnRH-a administration preferentially increased abdominal fat, as measured by single-slice computed tomography imaging and total body dual- energy x-ray absorptiometry, in hyperandrogenic anovulatory women.

Original languageEnglish (US)
Pages (from-to)94-101
Number of pages8
JournalFertility and Sterility
Volume70
Issue number1
DOIs
StatePublished - Jul 1998

Fingerprint

Adiposity
Gonadotropin-Releasing Hormone
Abdominal Fat
Body Fat Distribution
Hyperandrogenism
Leg
Waist-Hip Ratio
Abdomen
Body Mass Index
Fats
Tomography
X-Rays
Subcutaneous Fat
Therapeutics
Adipose Tissue
Outcome Assessment (Health Care)
Prospective Studies
Weights and Measures
Research

Keywords

  • Androgens
  • Body fat distribution
  • Hyperandrogenic anovulation

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. / Dumesic, Daniel A.; Abbott, David H.; Eisner, Joel R.; Herrmann, Rebekah R.; Reed, Judd E.; Welch, Timothy J.; Jensen, Michael Dennis.

In: Fertility and Sterility, Vol. 70, No. 1, 07.1998, p. 94-101.

Research output: Contribution to journalArticle

Dumesic, Daniel A. ; Abbott, David H. ; Eisner, Joel R. ; Herrmann, Rebekah R. ; Reed, Judd E. ; Welch, Timothy J. ; Jensen, Michael Dennis. / Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. In: Fertility and Sterility. 1998 ; Vol. 70, No. 1. pp. 94-101.
@article{93eede5405d543eeac73d692efa16b79,
title = "Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women",
abstract = "Objective: To determine whether hyperandrogenism in anovulatory women affects body fat distribution. Design: Prospective nonrandomized study. Setting: An academic research environment. Patient(s): Ten hyperandrogenic anovulatory patients and 10 healthy women matched by body mass index. Intervention(s): Regional body fat analysis was performed before and after 3 months of GnRH analogue (GnRH-a) therapy. Main Outcome Measure(s): Body fat distribution was measured by waist-to-hip circumference ratio, single-slice computed tomography imaging (L2-3 interspace), and total body dual-energy x- ray absorptiometry. Result(s): Weight, body mass index, waist-to-hip circumference ratio, total body and leg fat mass, and subcutaneous adipose area were unaffected by the presence of hyperandrogenism or the use of GnRH- a therapy. Basal abdominal fat mass, abdomen-to-leg fat mass ratio, visceral adipose area, and total visceral adipose volume were comparable in both study groups. The abdominal fat mass increased in both groups during GnRH-a therapy, whereas the abdomen-to-leg fat mass ratio rose significantly only in the hyperandrogenic patients. During GnRH-a therapy, the hyperandrogenic patients demonstrated a significant increase in visceral adipose area compared with the healthy women so that total visceral adipose volume increased significantly in the former but not the latter. Conclusion(s): Three months of GnRH-a administration preferentially increased abdominal fat, as measured by single-slice computed tomography imaging and total body dual- energy x-ray absorptiometry, in hyperandrogenic anovulatory women.",
keywords = "Androgens, Body fat distribution, Hyperandrogenic anovulation",
author = "Dumesic, {Daniel A.} and Abbott, {David H.} and Eisner, {Joel R.} and Herrmann, {Rebekah R.} and Reed, {Judd E.} and Welch, {Timothy J.} and Jensen, {Michael Dennis}",
year = "1998",
month = "7",
doi = "10.1016/S0015-0282(98)00098-3",
language = "English (US)",
volume = "70",
pages = "94--101",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women

AU - Dumesic, Daniel A.

AU - Abbott, David H.

AU - Eisner, Joel R.

AU - Herrmann, Rebekah R.

AU - Reed, Judd E.

AU - Welch, Timothy J.

AU - Jensen, Michael Dennis

PY - 1998/7

Y1 - 1998/7

N2 - Objective: To determine whether hyperandrogenism in anovulatory women affects body fat distribution. Design: Prospective nonrandomized study. Setting: An academic research environment. Patient(s): Ten hyperandrogenic anovulatory patients and 10 healthy women matched by body mass index. Intervention(s): Regional body fat analysis was performed before and after 3 months of GnRH analogue (GnRH-a) therapy. Main Outcome Measure(s): Body fat distribution was measured by waist-to-hip circumference ratio, single-slice computed tomography imaging (L2-3 interspace), and total body dual-energy x- ray absorptiometry. Result(s): Weight, body mass index, waist-to-hip circumference ratio, total body and leg fat mass, and subcutaneous adipose area were unaffected by the presence of hyperandrogenism or the use of GnRH- a therapy. Basal abdominal fat mass, abdomen-to-leg fat mass ratio, visceral adipose area, and total visceral adipose volume were comparable in both study groups. The abdominal fat mass increased in both groups during GnRH-a therapy, whereas the abdomen-to-leg fat mass ratio rose significantly only in the hyperandrogenic patients. During GnRH-a therapy, the hyperandrogenic patients demonstrated a significant increase in visceral adipose area compared with the healthy women so that total visceral adipose volume increased significantly in the former but not the latter. Conclusion(s): Three months of GnRH-a administration preferentially increased abdominal fat, as measured by single-slice computed tomography imaging and total body dual- energy x-ray absorptiometry, in hyperandrogenic anovulatory women.

AB - Objective: To determine whether hyperandrogenism in anovulatory women affects body fat distribution. Design: Prospective nonrandomized study. Setting: An academic research environment. Patient(s): Ten hyperandrogenic anovulatory patients and 10 healthy women matched by body mass index. Intervention(s): Regional body fat analysis was performed before and after 3 months of GnRH analogue (GnRH-a) therapy. Main Outcome Measure(s): Body fat distribution was measured by waist-to-hip circumference ratio, single-slice computed tomography imaging (L2-3 interspace), and total body dual-energy x- ray absorptiometry. Result(s): Weight, body mass index, waist-to-hip circumference ratio, total body and leg fat mass, and subcutaneous adipose area were unaffected by the presence of hyperandrogenism or the use of GnRH- a therapy. Basal abdominal fat mass, abdomen-to-leg fat mass ratio, visceral adipose area, and total visceral adipose volume were comparable in both study groups. The abdominal fat mass increased in both groups during GnRH-a therapy, whereas the abdomen-to-leg fat mass ratio rose significantly only in the hyperandrogenic patients. During GnRH-a therapy, the hyperandrogenic patients demonstrated a significant increase in visceral adipose area compared with the healthy women so that total visceral adipose volume increased significantly in the former but not the latter. Conclusion(s): Three months of GnRH-a administration preferentially increased abdominal fat, as measured by single-slice computed tomography imaging and total body dual- energy x-ray absorptiometry, in hyperandrogenic anovulatory women.

KW - Androgens

KW - Body fat distribution

KW - Hyperandrogenic anovulation

UR - http://www.scopus.com/inward/record.url?scp=0032124873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032124873&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(98)00098-3

DO - 10.1016/S0015-0282(98)00098-3

M3 - Article

C2 - 9660428

AN - SCOPUS:0032124873

VL - 70

SP - 94

EP - 101

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -